The latest collaboration marks Apollo’s sixth agreement with a research institution
Category: Oncology
Affecting over 250,000 people, bowel cancer is the fourth most common cancer in the UK
The most commonly diagnosed cancer in men in the UK leads to over 12,000 annual deaths
The most globally prevalent cancers include breast, lung, bowel and prostate cancers
Myricx Bio’s therapies include treatments for breast, lung and colorectal cancer
Aggressive prostate cancer accounts for up to 15% of all prostate cancer diagnoses
Breast cancer is the most common cancer in the UK, accounting for 15% of all cancers
Cancer was estimated to be responsible for more than 18 million cases worldwide in 2020
The installation will double the capacity of cancer genomic testing using robotic automation
The leading cause of cancer globally accounts for an estimated 1.8 million deaths annually